Adjaye J., Bolton V. & Monk M. (1999). Developmental expression of specific genes detected in high-quality cDNA libraries from single human preimplantation embryos. Gene 237, 373–83.
Alevizopoulos K., Vlach J., Hennecke S. & Amati B. (1997). Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J. 16, 5322–33.
Bayreuther K., Rodemann H.P., Hommel R., Dittmann K., Albiez M. & Francz P.I. (1988). Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc. Natl. Acad. Sci. USA 85, 5112–6.
Boer B., Kopp J., Mallanna S., Desler M., Chakravarthy H., Wilder P.J., Bernadt C. & Rizzino A. (2007). Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 35, 1773–86.
Cho K.A., Ryu S.J., Oh Y.S., Park J.H., Lee J.W., Kim H.P., Kim K.T., Jang I.S. & Park S.C. (2004). Morphological adjustment of senescent cells by modulating caveolin-1 status. J. Biol. Chem. 279, 42270–8.
DeVeale B., Brokhman I., Mohseni P., Babak T., Yoon C., Lin A., Onishi K., Tomilin A., Pevny L., Zandstra P.W., Nagy A. & van der Kooy D. (2013). Oct4 is required ~E7.5 for proliferation in the primitive streak. PLoS Genetics 9, e1003957.
Downward J. (1997). Cell cycle: routine role for Ras. Curr. Biol. 7, R258–60.
Fan Y.X., Gu C.H., Zhang Y.L., Zhong B.S., Wang L.Z., Zhou Z.R., Wang Z.Y., Jia R.X. & Wang F. (2013). Oct4 and Sox2 overexpression improves the proliferation and differentiation of bone mesenchymal stem cells in Xiaomeishan porcine. Genetics Mol. Res. 12, 6067–79.
Goto T., Adjaye J., Rodeck C.H. & Monk M. (1999). Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. Mol. Hum. Reprod. 5, 851–60.
Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A. & Weinberg R.A. (1994). Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91, 709–13.
Hochedlinger K., Yamada Y., Beard C. & Jaenisch R. (2005). Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121, 465–77.
Kinikoglu B., Kong Y.W. & Liao E.C. (2014). Characterization of cultured multipotent zebrafish neural crest cells. Exp. Biol. Med. 239, 159–68.
Kong Y.W., Jing G., Yan Z.G., Li C. Z., Gong N.P., Zhu F.J., Li D.X., Zhang Y.R., Zheng G.L., Wang H.Z., Xie L.P. & Zhang R.Q. (2009). Cloning and characterization of Prisilkin-39, a novel matrix protein serving a dual role in the prismatic layer formation from the oyster Pinctada fucata. J. Biol. Chem. 284, 10841–54.
Kwon D.J., Jeon H., Oh K.B., Ock S.A., Im G.S., Lee S.S., Im S.K., Lee J.W., Oh S.J., Park J.K. & Hwang S. (2013). Generation of leukemia inhibitory factor-dependent induced pluripotent stem cells from the Massachusetts General Hospital miniature pig. BioMed Res. Int. 2013, 140639.
Lee E., Lee S.H., Kim S., Jeong Y.W., Kim J.H., Koo O.J., Park S.M., Hashem M.A., Hossein M.S., Son H.Y., Lee C.K., Hwang W.S., Kang S.K. & Lee B.C. (2006a). Analysis of nuclear reprogramming in cloned miniature pig embryos by expression of Oct-4 and Oct-4 related genes. Biochem. Biophys. Res. Commun. 348, 1419–28.
Lee J., Go Y., Kang I., Han Y.M. & Kim J. (2010). Oct-4 controls cell-cycle progression of embryonic stem cells. Biochem. J. 426, 171–81.
Lee J., Kim H.K., Rho J.Y., Han Y.M. & Kim J. (2006b). The human OCT-4 isoforms differ in their ability to confer self-renewal. J. Biol. Chem. 281, 33554–65.
Li C., Yan Y., Ji W., Bao L., Qian H., Chen L., Wu M., Chen H., Li Z. & Su C. (2012). OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS One 7, e49693.
Liu K., Ji G., Mao J., Liu M., Wang L., Chen C. & Liu L. (2012). Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors. Cell. Reprogram. 14, 505–13.
Livak K.J. & Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–8.
Mountford P., Nichols J., Zevnik B., O’Brien C. & Smith A. (1998). Maintenance of pluripotential embryonic stem cells by stem cell selection. Reprod. Fertil. Dev. 10, 527–33.
Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H. & Smith A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–91.
Niwa H., Miyazaki J. & Smith A.G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372–6.
Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M. & Hamada H. (1990). A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60, 461–72.
Park K.M., Cha S.H., Ahn C. & Woo H.M. (2013). Generation of porcine induced pluripotent stem cells and evaluation of their major histocompatibility complex protein expression in vitro. Vet. Res. Commun. 37, 293–301.
Park S.J., Cho B., Koo O.J., Kim H., Kang J.T., Hurh S., Kim S.J., Yeom H.J., Moon J., Lee E.M., Choi J.Y., Hong J.H., Jang G., Hwang J.I., Yang J., Lee B.C. & Ahn C. (2014). Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide. Transgenic Res. 23, 407–19.
Pesce M., Gross M.K. & Scholer H.R. (1998). In line with our ancestors: Oct-4 and the mammalian germ. BioEssays 20, 722–32.
Ruley H.E. (1990). Transforming collaborations between Ras and nuclear oncogenes. Cancer Cells 2, 258–68.
Serrano M., Lin A.W., McCurrach M.E., Beach D. & Lowe S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602.
Weinberg R.A. (1989). Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49, 3713–21.
Yoshioka K., Suzuki C., Tanaka A., Anas I.M. & Iwamura S. (2002). Birth of piglets derived from porcine zygotes cultured in a chemically defined medium. Biol. Reprod. 66, 112–9.
Yuan Y., Lee K., Park K.W., Spate L.D., Prather R.S., Wells K.D. & Roberts R.M. (2014). Cell cycle synchronization of leukemia inhibitory factor (LIF)-dependent porcine-induced pluripotent stem cells and the generation of cloned embryos. Cell Cycle 13, 1265–76.
Zhang J.H., Chung T.D. & Oldenburg K.R. (1999). A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67–73.
Zhang X., Neganova I., Przyborski S., Yang C., Cooke M., Atkinson S.P., Anyfantis G., Fenyk S., Keith W.N., Hoare S.F., Hughes O., Strachan T., Stojkovic M., Hinds P.W., Armstrong L. & Lako M. (2009). A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J. Cell Biol. 184, 67–82.
Zhang Y., Wei C., Zhang P., Li X., Liu T., Pu Y., Li Y., Cao Z., Cao H., Liu Y. & Zhang X. (2014). Efficient reprogramming of naive-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system. PLoS One 9, e85089.